MAJESTY: A Phase 3, Randomized, Open-Label, Active Comparator-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy

Authors: Fernando C. Fervenza, Loreto Gesualdo, Gianna Mastroianni-Kirsztajn, Fan Fan Hou, Gerald B. Appel, Sylvie Prot, Eriola Berisha, Leena Khatri, Tom Parsons, Ed Spinks, Heather Boston, William Riboulet, Xiaoyan Han, Debbie Chen, Andrew S. Bomback

Published: 2024-10-28

DOI: 10.1681/asn.2024bg7j9nj3

Keywords: No keywords found.

Abstract:
No abstract found.

Source: